Reset

Advanced Filters
[Full Session] Welcome and Keynote Address
11:00am - 11:40am Eastern - June 15, 2020
Deborah L. Johnson, PhD, Keystone Symposia on Cellular and Molecular Biology; Rino Rappuoli, PhD, GlaxoSmithKline Vaccines; Dr. Anthony S. Fauci, MD, NIAID, National Institutes of Health

Monday
Welcome from Our CEO
11:00am - 11:05am Eastern - June 15, 2020
Deborah L. Johnson, PhD, Keystone Symposia on Cellular and Molecular Biology

Monday
Organizer Welcome | Day 1
11:05am - 11:15am Eastern - June 15, 2020
Rino Rappuoli, PhD, GlaxoSmithKline Vaccines

Monday
Transforming Vaccinology: Pandemic Preparedness and the Response to COVID-19
11:15am - 11:40am Eastern - June 15, 2020
Dr. Anthony S. Fauci, MD, NIAID, National Institutes of Health


In this Keynote Address, given on June 15, 2020 as part of the eSymposia “Vaccinology in the Age of Pandemics: Strategies Against COVID-19 & Other Global Threats,” Dr. Anthony Fauci outlines the latest vaccinology advances and approaches that have vastly accelerated the development of COVID-19 vaccines.

Dr. Fauci credits recent advances in technology for enabling this unprecedented rapid response, which in just the last few years have transformed vaccinology capabilities. These include:

  • Rapid genetic sequencing of new pathogens
  • Structure-based vaccine design and reverse vaccinology approaches
  • New and diverse vaccine platforms combined with improved adjuvants
  • Humanized animal models for vaccine testing

In addition, new preparedness strategies have accelerated vaccine development efforts. Since the early 2000s, researchers have been working preemptively on vaccines for emerging pathogens, and can now apply lesson learned from these efforts in COVID-19 vaccine design, development and testing. Meanwhile, preparation of clinical trial sites, manufacturing and other logistic considerations in the testing and deployment of a vaccine are critical to have ready prior to launch.

Ultimately, new partnerships between public and private sectors have enabled all of these pieces to come together at “warp speed” in the face of this new pandemic.


Explore more on the latest vaccinology advances and approaches from the eSymposia “Vaccinology in the Age of Pandemics: Strategies Against COVID-19 & Other Global Threats,” available on-demand through VKS:

custom image



[Full Session] Structure-Based Antigen Design
11:40am - 12:35pm Eastern - June 15, 2020
Barney S. Graham, MD, PhD, NIAID, National Institutes of Health; Neil P. King, PhD, University of Washington

Monday
Immunogen Design Strategies for COVID-19, RSV, Influenza and Other Enveloped Viruses
11:40am - 12:00pm Eastern - June 15, 2020
Barney S. Graham, MD, PhD, NIAID, National Institutes of Health
Track: Structure-Based Antigen Design

Monday
Structure-Based Design of Novel Nanoparticle Vaccine Platforms
12:00pm - 12:20pm Eastern - June 15, 2020
Neil P. King, PhD, University of Washington
Track: Structure-Based Antigen Design

Monday
Live Q/A with Drs. Graham and King
12:20pm - 12:35pm Eastern - June 15, 2020
Barney S. Graham, MD, PhD, NIAID, National Institutes of Health; Neil P. King, PhD, University of Washington
Track: Structure-Based Antigen Design

[Full Session] Antigen Presentation and Delivery
12:35pm - 01:35pm Eastern - June 15, 2020
Gabriel D. Victora, PhD, Rockefeller University; Robert A. Seder, MD, NIAID, National Institutes of Health

Monday
Clonal Dynamics of Germinal Centers in the Steady-State Gut
12:35pm - 12:55pm Eastern - June 15, 2020
Gabriel D. Victora, PhD, Rockefeller University
Track: Antigen Presentation and Delivery

Monday
IV Vaccination: A Paradigm for Inducing Tissue Resident T cells Against TB and Malaria
12:55pm - 01:20pm Eastern - June 15, 2020
Robert A. Seder, MD, NIAID, National Institutes of Health
Track: Antigen Presentation and Delivery

Monday
Live Q/A with Drs. Victora and Seder
01:20pm - 01:35pm Eastern - June 15, 2020
Robert A. Seder, MD, NIAID, National Institutes of Health; Gabriel D. Victora, PhD, Rockefeller University
Track: Antigen Presentation and Delivery

[Full Session] Therapeutic Vaccines
01:35pm - 02:30pm Eastern - June 15, 2020
Ulrike Protzer, MD, Technische Universität München; Catherine J. Wu, MD, Dana-Farber Cancer Institute

Monday
Vaccines Against Tumor Neoantigens
01:35pm - 01:55pm Eastern - June 15, 2020
Catherine J. Wu, MD, Dana-Farber Cancer Institute
Track: Therapeutic Vaccines

Monday
Therapeutic HBV Vaccines
01:55pm - 02:15pm Eastern - June 15, 2020
Ulrike Protzer, MD, Technische Universität München
Track: Therapeutic Vaccines

Monday
Live Q/A with Drs. Wu and Protzer
02:15pm - 02:30pm Eastern - June 15, 2020
Catherine J. Wu, MD, Dana-Farber Cancer Institute; Ulrike Protzer, MD, Technische Universität München
Track: Therapeutic Vaccines

[Full Session] Human Monoclonal Antibodies
02:30pm - 03:30pm Eastern - June 15, 2020
Antonio Lanzavecchia, MD, Institute for Research in Biomedicine; Hedda Wardemann, PhD, German Cancer Research Center

Monday
Dissecting Antibody Responses to Plasmodium Falciparum Circumsporozoite Protein for the Development of a Malaria Vaccine
02:30pm - 02:45pm Eastern - June 15, 2020
Hedda Wardemann, PhD, German Cancer Research Center
Track: Human Monoclonal Antibodies

Monday
Human Monoclonals for COVID-19 Passive Immunization and Antigen Discovery
02:45pm - 03:05pm Eastern - June 15, 2020
Antonio Lanzavecchia, MD, Institute for Research in Biomedicine
Track: Human Monoclonal Antibodies

Monday
Live Q/A with Drs. Lanzavecchia and Wardemann
03:05pm - 03:20pm Eastern - June 15, 2020
Antonio Lanzavecchia, MD, Institute for Research in Biomedicine; Hedda Wardemann, PhD, German Cancer Research Center
Track: Human Monoclonal Antibodies

[Full Session] RNA Vaccines
11:00am - 11:50am Eastern - June 16, 2020
Lynda M. Stuart, MD, PhD, Bill & Melinda Gates Foundation; Christine Shaw, PhD, Moderna; Robin Shattock, PhD, Imperial College London

Tuesday
mRNA Vaccines Against Viruses
11:05am - 11:20am Eastern - June 16, 2020
Track: RNA Vaccines

Tuesday
Development of a COVID-19 Self-Amplifying RNA Vaccine
11:20am - 11:35am Eastern - June 16, 2020
Robin Shattock, PhD, Imperial College London
Track: RNA Vaccines

Tuesday
Live Q/A with Drs. Shaw and Shattock
11:35am - 11:50am Eastern - June 16, 2020
Christine Shaw, PhD, Moderna; Lynda M. Stuart, MD, PhD, Bill & Melinda Gates Foundation
Track: RNA Vaccines

Systems Biology
11:50am - 12:50pm Eastern - June 16, 2020
Galit Alter, PhD, MIT and Harvard University; Bali Pulendran, PhD, Stanford University School of Medicine

Tuesday
Applying Systems Serology to Define Humoral Correlates of Immunity Against Malaria
11:50am - 12:15pm Eastern - June 16, 2020
Galit Alter, PhD, MIT and Harvard University
Track: Systems Biology

Tuesday
Human Immunity to SARS-CoV2
12:15pm - 12:35pm Eastern - June 16, 2020
Bali Pulendran, PhD, Stanford University School of Medicine
Track: Systems Biology

Tuesday
Live Q/A with Drs. Alter and Pulendran
12:35pm - 12:50pm Eastern - June 16, 2020
Galit Alter, PhD, MIT and Harvard University; Bali Pulendran, PhD, Stanford University School of Medicine
Track: Systems Biology

[Full Session] Immune Response
12:50pm - 01:40pm Eastern - June 16, 2020
Alessandro Sette, PhD, La Jolla Institute for Immunology; Yasmine Belkaid, PhD, NIAID, National Institutes of Health

Tuesday
SARS CoV2 Specific T cell Responses in Exposed and Non-exposed Subjects
12:50pm - 01:10pm Eastern - June 16, 2020
Alessandro Sette, PhD, La Jolla Institute for Immunology
Track: Immune Response

Tuesday
Microbiota Control of Tissue Immunity
01:10pm - 01:25pm Eastern - June 16, 2020
Yasmine Belkaid, PhD, NIAID, National Institutes of Health
Track: Immune Response

Tuesday
Live Q/A with Drs. Sette and Belkaid
01:25pm - 01:40pm Eastern - June 16, 2020
Alessandro Sette, PhD, La Jolla Institute for Immunology; Yasmine Belkaid, PhD, NIAID, National Institutes of Health
Track: Immune Response

eSymposia Panel Discussion: Facing COVID-19 and other Emerging Infections
01:40pm - 03:15pm Eastern - June 16, 2020
Rino Rappuoli, PhD, Moderator, GlaxoSmithKline Vaccines; Richard Hatchett, MD, Coalition for Epidemic Preparedness Innovations, CEPI; George Fu Gao, PhD, Institute of Microbiology, Chinese Academy of Sciences; Lynda M. Stuart, MD, PhD, Bill & Melinda Gates Foundation
Tags: ePanel

Tuesday
Introduction Dr. Rino Rappuoli
01:40pm - 01:45pm Eastern - June 16, 2020
Rino Rappuoli, PhD, GlaxoSmithKline Vaccines
Track: Facing COVID-19 and other Emerging Infections

Tuesday
Introduction Dr. Richard Hatchett
01:45pm - 01:50pm Eastern - June 16, 2020
Richard Hatchett, MD, Coalition for Epidemic Preparedness Innovations, CEPI
Track: Facing COVID-19 and other Emerging Infections

Tuesday
Introduction Dr. George Fu Gao
01:50pm - 01:55pm Eastern - June 16, 2020
George Fu Gao, PhD, Institute of Microbiology, Chinese Academy of Sciences
Track: Facing COVID-19 and other Emerging Infections

Tuesday
Introduction Dr. Lynda M. Stuart
01:55pm - 02:00pm Eastern - June 16, 2020
Lynda M. Stuart, MD, PhD, Bill & Melinda Gates Foundation
Track: Facing COVID-19 and other Emerging Infections

Tuesday
ePanel Discussion | Facing COVID-19 and other Emerging Infections
02:00pm - 03:00pm Eastern - June 16, 2020
Rino Rappuoli, PhD, Moderator, GlaxoSmithKline Vaccines; Richard Hatchett, MD, Coalition for Epidemic Preparedness Innovations, CEPI; George Fu Gao, PhD, Institute of Microbiology, Chinese Academy of Sciences; Lynda M. Stuart, MD, PhD, Bill & Melinda Gates Foundation
Track: Facing COVID-19 and other Emerging Infections